JAMP POSACONAZOLE
Google image searchProduct monograph
Active ingredient
posaconazole, 40 MG/ML
DIN: 02530333
Dosage form(s): SUSPENSION
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 24-MAY-2023
ATC:
- J02 — ANTIMYCOTICS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J02A — ANTIMYCOTICS FOR SYSTEMIC USE (ATC, ATC/DDD)
- J02AC — Triazole derivatives (ATC, ATC/DDD)
- J02AC04 — POSACONAZOLE (ATC/DDD)
Reference brand drug: Posanol
